259 related articles for article (PubMed ID: 25495223)
1. Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance.
Wojtuszkiewicz A; Assaraf YG; Maas MJ; Kaspers GJ; Jansen G; Cloos J
Expert Opin Drug Metab Toxicol; 2015 May; 11(5):673-89. PubMed ID: 25495223
[TBL] [Abstract][Full Text] [Related]
2. The role of alternative splicing in cancer: From oncogenesis to drug resistance.
Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J
Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093
[TBL] [Abstract][Full Text] [Related]
3. Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer.
Jyotsana N; Heuser M
Expert Opin Ther Targets; 2018 Feb; 22(2):107-121. PubMed ID: 29235382
[TBL] [Abstract][Full Text] [Related]
4. [Disturbances of alternative splicing in cancer].
Wiszomirska H; Piekiełko-Witkowska A; Nauman A
Postepy Biochem; 2011; 57(3):257-65. PubMed ID: 22235651
[TBL] [Abstract][Full Text] [Related]
5. [Pre-mRNA splicing: when the spliceosome loses ground].
Dujardin G; Daguenet É; Bernard DG; Flodrops M; Durand S; Chauveau A; El Khoury F; Le Jossic-Corcos C; Corcos L
Med Sci (Paris); 2016 Dec; 32(12):1103-1110. PubMed ID: 28044974
[TBL] [Abstract][Full Text] [Related]
6. Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy.
Mehterov N; Kazakova M; Sbirkov Y; Vladimirov B; Belev N; Yaneva G; Todorova K; Hayrabedyan S; Sarafian V
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356101
[TBL] [Abstract][Full Text] [Related]
7. The role of alternative splicing in cancer.
Singh B; Eyras E
Transcription; 2017 Mar; 8(2):91-98. PubMed ID: 28005460
[TBL] [Abstract][Full Text] [Related]
8. [Pre-mRNA alternative splicing in cancer: functional impact, molecular mechanisms and therapeutic perspectives].
Revil T; Shkreta L; Chabot B
Bull Cancer; 2006 Sep; 93(9):909-19. PubMed ID: 16980234
[TBL] [Abstract][Full Text] [Related]
9. Alternative splicing: an emerging topic in molecular and clinical oncology.
Pajares MJ; Ezponda T; Catena R; Calvo A; Pio R; Montuenga LM
Lancet Oncol; 2007 Apr; 8(4):349-57. PubMed ID: 17395108
[TBL] [Abstract][Full Text] [Related]
10. RNA splicing, cell signaling, and response to therapies.
Abou Faycal C; Gazzeri S; Eymin B
Curr Opin Oncol; 2016 Jan; 28(1):58-64. PubMed ID: 26575690
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing and cancer metastasis: prognostic and therapeutic applications.
Marzese DM; Manughian-Peter AO; Orozco JIJ; Hoon DSB
Clin Exp Metastasis; 2018 Aug; 35(5-6):393-402. PubMed ID: 29845349
[TBL] [Abstract][Full Text] [Related]
12. Pre-mRNA splicing-associated diseases and therapies.
Love SL; Emerson JD; Koide K; Hoskins AA
RNA Biol; 2023 Jan; 20(1):525-538. PubMed ID: 37528617
[TBL] [Abstract][Full Text] [Related]
13. Roles and mechanisms of alternative splicing in cancer - implications for care.
Bonnal SC; López-Oreja I; Valcárcel J
Nat Rev Clin Oncol; 2020 Aug; 17(8):457-474. PubMed ID: 32303702
[TBL] [Abstract][Full Text] [Related]
14. Non-canonical functions of spliceosome components in cancer progression.
Ivanova OM; Anufrieva KS; Kazakova AN; Malyants IK; Shnaider PV; Lukina MM; Shender VO
Cell Death Dis; 2023 Feb; 14(2):77. PubMed ID: 36732501
[TBL] [Abstract][Full Text] [Related]
15. Targeting the spliceosome machinery: A new therapeutic axis in cancer?
Eymin B
Biochem Pharmacol; 2021 Jul; 189():114039. PubMed ID: 32417188
[TBL] [Abstract][Full Text] [Related]
16. Regulation of chemoresistance via alternative messenger RNA splicing.
Eblen ST
Biochem Pharmacol; 2012 Apr; 83(8):1063-72. PubMed ID: 22248731
[TBL] [Abstract][Full Text] [Related]
17. The Role of Alternative Splicing in Cancer: Regulatory Mechanism, Therapeutic Strategy, and Bioinformatics Application.
Pan YJ; Liu BW; Pei DS
DNA Cell Biol; 2022 Sep; 41(9):790-809. PubMed ID: 35947859
[TBL] [Abstract][Full Text] [Related]
18. Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing.
Mansfield SG; Kole J; Puttaraju M; Yang CC; Garcia-Blanco MA; Cohn JA; Mitchell LG
Gene Ther; 2000 Nov; 7(22):1885-95. PubMed ID: 11127576
[TBL] [Abstract][Full Text] [Related]
19. Modulating splicing with small molecular inhibitors of the spliceosome.
Effenberger KA; Urabe VK; Jurica MS
Wiley Interdiscip Rev RNA; 2017 Mar; 8(2):. PubMed ID: 27440103
[TBL] [Abstract][Full Text] [Related]
20. Quantifying the ratio of spliceosome components assembled on pre-mRNA.
Neufeld N; Brody Y; Shav-Tal Y
Methods Mol Biol; 2014; 1126():257-69. PubMed ID: 24549670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
